Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/q/kary/) was not found.

Search q kary at Google

Search q kary at Yahoo

Search q kary at Msn

Google
 
(Date:10/14/2008)...r 14, 2008Three years after Hurricane Katrina deva...uses of the destruction of the city,s floodwall sy... Entomologist (Vol. 54, No. 3) suggests that Form... Author Gregg Henderson, a professor at the Louis...n subterranean termites (Coptotermes formosanus Sh...
(Date:10/14/2008)... who has discovered new communication channels in ...o communicate data through these channels, will be...ors Hall of Fame. His work will eventually allow m...nts to communicate information and data faster and... The National Science Foundation has supported thi...
(Date:10/14/2008)...or Health and Nutrition announced the publication ...ten associated with the health benefits of red win...cts. In the September 24 edition of the Journal ...port that cocoa powder, baking chocolate and dark ...ol, a naturally occurring antioxidant. , "This ...
(Date:10/14/2008)...earchers at the Johns Hopkins Bloomberg School of ...ing the antiretroviral drug efavirenz were more li...erience virologic failure and death compared to pa...requently prescribed drug for patients undergoing ...he treatment of HIV/AIDS in sub-Saharan Africa, wh...
Breaking Biology News(10 mins):Did termites help Katrina destroy New Orleans floodwalls? 2NJIT professor's research suggests changes in underwater data communications 2Resveratrol, red wine compound linked to health, also found in dark chocolate and cocoa 2Efavirenz-based initial therapies associated with better outcomes in HIV-infected adults 2Microarray sequence capture speeds large scale resequencing of targeted genomic regions 801 1Microarray sequence capture speeds large scale resequencing of targeted genomic regions 801 2Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients 3652 1Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients 3652 2New Analyses of long term LIALDA 28mesalamine 29 data presented at ACG 3648 1New Analyses of long term LIALDA 28mesalamine 29 data presented at ACG 3648 2New Analyses of long term LIALDA 28mesalamine 29 data presented at ACG 3648 3New Analyses of long term LIALDA 28mesalamine 29 data presented at ACG 3648 4Pennsylvania Trauma Center Accreditation Status 3645 1Pennsylvania Trauma Center Accreditation Status 3645 2
...gh-quality randomized clinical trials have determi...native medication, may not have any significant in...iver disease or hepatitis B or C liver disease. T...l of Gastroenterology. , According to the previous... possess properties that protect against various h...
...t the Oregon National Primate Research Center at O...discovered one key gene that appears to control ho...The finding has significant implications for the s... injury, and other conditions or diseases that mig...cells. The research is published in the current on...
...s that produce bird feathers have been visualized ...itial step in a scientific journey that may ultima... research, published in the December 15 issue of t...minent stem-cell researchers from the Keck School ...ia. , "What we found is that feather stem cells a...
...entists is proposing that endangered California co...d sea lion rookeries so that the birds can once ag...eir ancestors did centuries ago. , The researchers...ons base their conclusion on the feeding behavior ...ey. Writing in the Nov. 7 online edition of the Pr...
Other Biology News:OHSU discovery sheds light into how stem cells become brain cells 2USC researchers track down the stem cells that create feathers 2USC researchers track down the stem cells that create feathers 3Seal rookeries could provide a reliable food source for endangered California condors, study finds 2Seal rookeries could provide a reliable food source for endangered California condors, study finds 3Seal rookeries could provide a reliable food source for endangered California condors, study finds 4Seal rookeries could provide a reliable food source for endangered California condors, study finds 5
(Date:10/15/2008)...esearchers, including scientists from the Universi... block the growth of neuroblastoma, a type of canc... in children. , Working with human cell lines an...,s (Oct. 16, 2008) online issue of Nature how th...at apparently contribute to neuroblastomas tumors...
(Date:10/15/2008)... Technology Studies (InHealth) has awarded $1.7 mi...hers at Johns Hopkins University, Northwestern Uni...ity and the University of Houston. , The fundin...cial impact of diagnostic and therapeutic medical ...onditions. , Researchers will explore the cost...
(Date:10/15/2008)...tes Will Increase Flu,Vaccination Rates, LAKEVILL...g this year,s,national presidential election, more...hrough polling places -- and two-thirds of them ar... of this unique,opportunity, nearly 200 flu shot c...es, including some early voting locations, across ...
(Date:10/15/2008)...l/ -- CTG HealthCare Solutions,(CTGHS), a leading ...firm,and a business unit of CTG (Nasdaq: CTGX ),...y, today announced that it was awarded a series of...mplementations., CTGHS is providing services to a...research program to support the project leadership...
Breaking Medicine News(10 mins):Health News:Scientists close in on method to fight deadly childhood cancer 2Health News:Scientists close in on method to fight deadly childhood cancer 3Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 2Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 3Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 4Health News:Convenience is Key to Adult Flu Vaccinations 2Health News:Convenience is Key to Adult Flu Vaccinations 3Health News:CTG HealthCare Solutions Announces New EPIC Implementation Engagements 2Health News:CTG HealthCare Solutions Announces New EPIC Implementation Engagements 3
...n Government has issued a warning to leave no ston...ey conducted by the health department found, nearl...tuned into consuming junk food or snacks on a dail...and vegetables are completely ignored in the diet....
...g program for cervical cancer has been called for ...following the announcement that a vaccine against ...land in four weeks time. Doctors have hailed the...ccine, Gardasil, as one of the biggest research su...
...nt discovery is that men have a 4- to 5-point IQ a...ed by a study conducted on 100,000 17- to 18-year-...uring the school years, the sex difference is not ...ster than boys. This is the reason why sex differe...
...sians including Indians are being hit the most by ...size-fits-all diagnosis done by doctors that fails...ex (BMI) - a measure of weight divided by height- ...e obesity. However, according to the experts, East...
Other Medicine News:Health News:Greater g factor in men responsible for sex differences in general mental ability 2Health News:Greater g factor in men responsible for sex differences in general mental ability 3
Kinase Buffer can be used to assay protein kinase activity
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C
Biology Products:
Modular flow cytometer with all options.
Compact mobile flow cytometer for any kind of cell analysis and absolute volumetric counting. The CyFlow SL analyzes forward and side scatter signals in combination with up to 3 fluorescence channels
The Cytomics FC 500 Series delivers flexible testing, powerful software and a user-friendly interface features that help researchers optimize their overall workflow efficiency while maintaining true
...stem features an extensive menu, ease of use, reli...rmance. The IMMULITE 1000 monitors onboard reagent...ple identification, and Remote Diagnostics. , ,...he IMMULITE) has been chosen for various types of ...
Medicine Products:
(Date:10/15/2008)...VELAND, Ohio and TEL AVIV, Israel, October 15 /PRN...o announce the completion of a Series,C round of g...l Funds,along with incumbent investor Early Stage... as Western Reserve Partners who served as the,com...ble Simbionix to,accelerate the already rapid grow...
(Date:10/15/2008)...pendent Medical Education Agency Expanding Industr...swire/ -- L&M Healthcare,Communications LLC, an in...,today announced the hiring of Todd Weinstein as V...ill leverage his experience in medical education a... Prior to joining L&M, he,served as Manager of Pub...
(Date:10/15/2008)...INE, Calif., Oct. 15 /- The increased...de has led to more costly medical,product developm...d,resource intensive actions by Sponsors to respon...change can be found in consulting organizations. G...ents from compliance errors,that can lead to adver...
(Date:10/14/2008)...NTAIN VIEW, Calif., Oct. 14 /- Based ... Frost & Sullivan recognizes ISTO,Technologies, In...ward for,Product Innovation for its novel InQu(R) ...represents the first commercial product launched b...sed platform technology., Although spinal fusions...
Breaking Biology Technology:Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3L&M Healthcare Communications LLC Expands Client Services With Executive Team Expansion 2Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 2Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 3Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bone Healing 2Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bone Healing 3Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bone Healing 4
...ge Major Laboratories , a Germantown manufacturer ...d pharmaceutical executive James Davidson as its c... is part of a global expansion strategy, places Da...ions. During his 23 years in the industry, Davidso...s division and for Parke-Davis/Warner-Lambert, whi...
...e some things they didn,t tell Jeanne Moreno when ...wo years ago. Under the circumstances, she,s just ...t chief information officer to join a large, globa... of a large portfolio of aging and obsolete busine...e unsupported platforms, under-managed data center...
...ly Speaker,s Task Force on Information Technology ...te technology implementations July 16 during its f...will focus on three Department of Workforce Devel...m 411 South of the State Capitol . , ,Projects th...nt Insurance Tax Enterprise System (SUITES), the E...
... Researchers in New Brunswick Scientific,s in-h...gy to achieve high antibiotic expression levels in...ces hygroscopicus. Using the BioFlo 6000 fermentor... augmented by the powerful supervisory capabilitie...cessful in optimizing the culture environment for,...
Other Biology Technology:CIO Leadership Series: Snap-On's Moreno offers lessons in IT transformation 2CIO Leadership Series: Snap-On's Moreno offers lessons in IT transformation 3CIO Leadership Series: Snap-On's Moreno offers lessons in IT transformation 4CIO Leadership Series: Snap-On's Moreno offers lessons in IT transformation 5Rapamycin Optimized in 100 Liter Fermentor Using BioCommand Control Strategys 2Rapamycin Optimized in 100 Liter Fermentor Using BioCommand Control Strategys 3
(Date:10/14/2008)...egulatory Clearance to Begin Phase I,Clinical Tria...-- Insmed Inc. (Nasdaq:,INSM), a developer of foll...unced that it has received approval from the Unite...latory Agency (MHRA) to initiate a Phase I,clinica...c (FOB) product,candidate, INS-20. Insmed,s INS-20...
(Date:10/14/2008)...ary Coverage of Targeted Cancer Therapies is In...n Resources, WALTHAM, Mass., Oct. 14 /PRNewswire/... research and advisory firms for pharmaceutical an...ted cancer agents in Phase,III clinical trials in ...t,Genentech/Roche/Chugai,s Avastin in early-stage ...
(Date:10/14/2008)...er 14 /- Arpida Ltd.,(SWX: ...from the U.S. Food,and Drug Administration (FDA) t...mittee will discuss the New Drug Application (NDA)...Skin Structure Infections,(cSSSI) during its meeti...an be requested by FDA as part of the review proce...
(Date:10/13/2008)... SPIRIT III Data Confirms Patients Treated, with X... Heart Attack or a Repeat Procedure Comp...3 /- Data from an independe...III randomized clinical,trials demonstrated that t...System continues to deliver clinically significant...
Breaking Medicine Technology:Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R) 4Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer 2Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer 3Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008 2Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5Pharmacopeia Acquires Selective Androgen Receptor Modulator 28SARM 29 Program from Bristol Myers Squibb 3641 1Pharmacopeia Acquires Selective Androgen Receptor Modulator 28SARM 29 Program from Bristol Myers Squibb 3641 2Pharmacopeia Acquires Selective Androgen Receptor Modulator 28SARM 29 Program from Bristol Myers Squibb 3641 3Pharmacopeia Acquires Selective Androgen Receptor Modulator 28SARM 29 Program from Bristol Myers Squibb 3641 4Pharmacopeia Acquires Selective Androgen Receptor Modulator 28SARM 29 Program from Bristol Myers Squibb 3641 5Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis 28PGD 29 1249 1Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis 28PGD 29 1249 2Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis 28PGD 29 1249 3Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease 508 1Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease 508 2Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease 508 3Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease 508 4New tool to assess excessive daytime sleepiness in adolescents published in JCSM 3635 1New tool to assess excessive daytime sleepiness in adolescents published in JCSM 3635 2
... patients treated with VELCADE, cyclophosphamide,...une 28, 2007 /PRNewswire-FirstCall/ -- Millennium,...tation of results,from clinical trials of VELCADE ...n / complete response(1) (CR) rates in previously,...ings were,presented at the prestigious 11th Intern...
...--(BUSINESS WIRE)--Jun 29, 2007 - The drug most,co...fate, is more,likely than another common treatment... women, according to a study from researchers at,L...versity School,of Medicine. Their findings suggest...pears similar, physicians should consider side,eff...
Other Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6Common Preterm Labor Drug Has More Side Effects Than Alternative,Finds Study from Packard Children's Hospital and Stanford 2Common Preterm Labor Drug Has More Side Effects Than Alternative,Finds Study from Packard Children's Hospital and Stanford 3Common Preterm Labor Drug Has More Side Effects Than Alternative,Finds Study from Packard Children's Hospital and Stanford 4